v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Condensed Consolidated Statements of Operations and Comprehensive Loss        
Revenue   $ 3 $ 40 $ 27
Cost of revenue   1 32 23
Gross profit   2 8 4
Other operating income $ 287 257 725 695
Operating expenses        
Research and development 1,504 1,568 3,938 4,104
Selling, general and administrative 1,578 1,268 4,784 4,025
(Gain)/loss on foreign currency transactions 43 118 75 186
Total operating expenses 3,125 2,954 8,797 8,315
Loss from operations (2,838) (2,695) (8,064) (7,616)
Non-operating income/(expense)        
Gain/(loss) on foreign currency transactions   (787) (249) 248
Transaction costs allocable to warrants       (198)
Change in fair value of the warrant liability   458 672 461
Interest income/(expense) (4) 2 5 8
Total non-operating income/(expense) (4) (327) 428 519
Loss before income taxes (2,842) (3,022) (7,636) (7,097)
Income tax expense     (1)  
Net loss (2,842) (3,022) (7,637) (7,097)
Other comprehensive loss:        
Foreign currency translation 125 850 281 (123)
Total comprehensive loss $ (2,717) $ (2,172) $ (7,356) $ (7,220)
Common share data:        
Basic net loss per common share (in dollars per share) $ (0.86) $ (1.78) $ (2.49) $ (5.82)
Diluted net loss per common share (in dollars per share) $ (0.86) $ (1.78) (4.80) $ (5.82)
Dividend per common share     $ (2.31)  
Weighted average number of basic shares outstanding (in shares) 3,308,975 1,701,166 3,068,110 1,219,450
Weighted average number of diluted shares outstanding (in shares) 3,308,975 1,701,166 3,068,110 1,219,450

Source